Alex J. Thompson - Publications

Affiliations: 
2001-2006 University of Michigan, Ann Arbor, Ann Arbor, MI 

189 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Fallon BP, Lautner-Csorba O, Thompson AJ, Lautner G, Kayden A, Johnson MD, Harvey SL, Langley MW, Peña AR, Bartlett RH, Hirschl RB. A pumpless artificial lung without systemic anticoagulation: The Nitric Oxide Surface Anticoagulation system. Journal of Pediatric Surgery. PMID 34649727 DOI: 10.1016/j.jpedsurg.2021.09.015  1
2021 Howell J, Majumdar A, Fink M, Byrne M, McCaughan G, Strasser SI, Crawford M, Hodgkinson P, Stuart KA, Tallis C, Chen J, Wigg A, Jones R, Jaques B, Jeffrey G, ... ... Thompson A, et al. Turning the tide on hepatitis C-related liver transplantation: the return on investment in hepatitis C treatment in Australia and New Zealand. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. PMID 34624175 DOI: 10.1002/lt.26329  1
2021 Lett AM, Lim A, Skinner C, Maurice J, Vergis N, Darzi A, Goldin R, Thursz M, Thompson AJ. Rapid, non-invasive measurement of gastric emptying rate using transcutaneous fluorescence spectroscopy. Biomedical Optics Express. 12: 4249-4264. PMID 34457412 DOI: 10.1364/BOE.424252  1
2021 Kim JA, Yeatman EM, Thompson AJ. Plasmonic optical fiber for bacteria manipulation-characterization and visualization of accumulation behavior under plasmo-thermal trapping. Biomedical Optics Express. 12: 3917-3933. PMID 34457389 DOI: 10.1364/BOE.425405  0.01
2021 Potkay JA, Thompson AJ, Toomasian J, Lynch W, Bartlett RH, Rojas-Peña A. Toward a Servoregulation Controller to Automate CO2 Removal in Wearable Artificial Lungs. Asaio Journal (American Society For Artificial Internal Organs : 1992). PMID 34380953 DOI: 10.1097/MAT.0000000000001551  1
2021 Mbuki R, Chileya S, Thompson AJ, Kelly P, Kayamba V. Rapid testing of gut permeability using oral fluorescein and confocal laser endomicroscopy in Zambian adults. Transactions of the Royal Society of Tropical Medicine and Hygiene. PMID 34118155 DOI: 10.1093/trstmh/trab083  1
2021 Thompson AJ, Bourke CD, Robertson RC, Shivakumar N, Edwards CA, Preston T, Holmes E, Kelly P, Frost G, Morrison DJ. Understanding the role of the gut in undernutrition: what can technology tell us? Gut. PMID 34103403 DOI: 10.1136/gutjnl-2020-323609  1
2021 Baggerman JO, Thompson AJ, Jennings MA, Hergenreder JE, Rounds W, Smith ZK, Johnson BJ. Effects of Encapsulated Methionine on Skeletal Muscle Growth and Development and Subsequent Feedlot Performance and Carcass Characteristics in Beef Steers. Animals : An Open Access Journal From Mdpi. 11. PMID 34072859 DOI: 10.3390/ani11061627  1
2021 Cutts JC, Quinn B, Seed CR, Kotsiou G, Pearson R, Scott N, Wilson DP, Harrod ME, Maher L, Caris S, Thompson AJ, Farrell M, Pink J, Hellard ME. A Systematic Review of Interventions Used to Increase Blood Donor Compliance with Deferral Criteria. Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie. 48: 118-129. PMID 33976612 DOI: 10.1159/000509027  1
2021 Thompson AJ, O'Leary PW, Miller A, Martineau S, Reece C, Breuer A, Eidem BW, Qureshi MY. Inter-observer and Inter-vendor Variability in Strain Measurements in Patients with Single Right Ventricular Anatomy. Pediatric Cardiology. PMID 33891133 DOI: 10.1007/s00246-021-02617-x  1
2021 Dryden SD, Anastasova S, Satta G, Thompson AJ, Leff DR, Darzi A. Rapid uropathogen identification using surface enhanced Raman spectroscopy active filters. Scientific Reports. 11: 8802. PMID 33888775 DOI: 10.1038/s41598-021-88026-9  1
2020 Skinner C, Thompson AJ, Thursz MR, Marchesi JR, Vergis N. Intestinal permeability and bacterial translocation in patients with liver disease, focusing on alcoholic aetiology: methods of assessment and therapeutic intervention. Therapeutic Advances in Gastroenterology. 13: 1756284820942616. PMID 33149761 DOI: 10.1177/1756284820942616  1
2020 Maurice J, Lett AM, Skinner C, Lim A, Richardson M, Thomas AP, Summers PA, Vyas K, Tadbier AW, Vilar R, Kuimova MK, Miodragovic S, Vergis N, Kelly P, Cordeiro MF, ... ... Thompson AJ, et al. Transcutaneous fluorescence spectroscopy as a tool for non-invasive monitoring of gut function: first clinical experiences. Scientific Reports. 10: 16169. PMID 32999336 DOI: 10.1038/s41598-020-73149-2  1
2020 Howell J, Pedrana A, Schroeder SE, Scott N, Aufegger L, Atun R, Baptista-Leite R, Hirnschal G, Hoen E', Hutchinson SJ, Lazarus JV, Olufunmilayo L, Peck R, Sharma M, Sohn AH, ... Thompson A, et al. A global investment framework for the elimination of hepatitis B. Journal of Hepatology. PMID 32971137 DOI: 10.1016/j.jhep.2020.09.013  1
2020 Shepherd RK, Carter P, Enke YL, Thompson A, Flynn B, Trang E, Dalrymple A, Fallon JB. Chronic intracochlear electrical stimulation at high charge densities: Reducing platinum dissolution. Journal of Neural Engineering. PMID 32916669 DOI: 10.1088/1741-2552/Abb7A6  1
2020 Baggerman JO, Smith ZK, Thompson AJ, Kim J, Hergenreder JE, Rounds W, Johnson BJ. Chromium propionate supplementation alters animal growth performance, carcass characteristics, and skeletal muscle properties in feedlot steers. Translational Animal Science. 4: txaa146. PMID 32905313 DOI: 10.1093/tas/txaa146  1
2020 Scott N, Kuschel C, Pedrana A, Schroeder S, Howell J, Thompson A, Wilson DP, Hellard M. A model of the economic benefits of global hepatitis C elimination: an investment case. The Lancet. Gastroenterology & Hepatology. PMID 32730785 DOI: 10.1016/S2468-1253(20)30008-X  1
2020 Basnayake C, Kamm MA, Stanley A, Wilson-O'Brien A, Burrell K, Lees-Trinca I, Khera A, Kantidakis J, Wong O, Fox K, Talley NJ, Liew D, Salzberg MR, Thompson AJ. Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial. The Lancet. Gastroenterology & Hepatology. PMID 32679040 DOI: 10.1016/S2468-1253(20)30215-6  1
2020 Traeger MW, Pedrana AE, van Santen DK, Doyle JS, Howell J, Thompson AJ, El-Hayek C, Asselin J, Polkinghorne V, Membrey D, Bramwell F, Carter A, Guy R, Stoové MA, Hellard ME, et al. The impact of universal access to direct-acting antiviral therapy on the hepatitis C cascade of care among individuals attending primary and community health services. Plos One. 15: e0235445. PMID 32603349 DOI: 10.1371/journal.pone.0235445  1
2020 Mishra G, Dev A, Paul E, Cheung W, Koukounaras J, Jhamb A, Marginson B, Lim BG, Simkin P, Borsaru A, Burnes J, Goodwin M, Ramachandra V, Spanger M, Lubel J, ... Thompson A, et al. Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation. Bmc Cancer. 20: 483. PMID 32471447 DOI: 10.1186/S12885-020-06806-4  1
2020 Thompson AJ, Ma LJ, Major T, Jeakle M, Lautner-Csorba O, Goudie MJ, Handa H, Rojas-Peña A, Potkay JA. Assessing and improving the biocompatibility of microfluidic artificial lungs. Acta Biomaterialia. PMID 32434076 DOI: 10.1016/J.Actbio.2020.05.008  1
2020 Pate A, Elliott RA, Gkountouras G, Thompson A, Emsley R, van Staa T. The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented. Pharmacoepidemiology and Drug Safety. PMID 32394495 DOI: 10.1002/Pds.5023  1
2020 Yuen L, Revill PA, Rosenberg G, Wagner J, Littlejohn M, Bayliss J, Jackson K, Tan SK, Gaggar A, Kitrinos K, Subramanian M, Gane E, Chan HL, Li X, Bowden S, ... Thompson A, et al. HBV variants are common in the "immune-tolerant"phase of chronic hepatitis B. Journal of Viral Hepatitis. PMID 32384174 DOI: 10.1111/Jvh.13318  1
2020 Allard NL, MacLachlan JH, Dev A, Dwyer J, Srivatsa G, Spelman T, Thompson AJ, Cowie BC. Adherence in chronic hepatitis B: associations between medication possession ratio and adverse viral outcomes. Bmc Gastroenterology. 20: 140. PMID 32381025 DOI: 10.1186/s12876-020-01219-w  1
2020 Scott N, Sacks-Davis R, Wade AJ, Stoove M, Pedrana A, Doyle JS, Thompson AJ, Wilson DP, Hellard ME. Australia needs to increase testing to achieve hepatitis C elimination. The Medical Journal of Australia. PMID 32167586 DOI: 10.5694/mja2.50544  1
2020 Howell DJ, Chan HL, Feld JJ, Hellard ME, Thompson AJ. Closing the stable door after the horse has bolted - should we be treating people with immune-tolerant chronic hepatitis B to prevent hepatocellular carcinoma? Gastroenterology. PMID 32088205 DOI: 10.1053/j.gastro.2020.02.027  1
2020 Quinn B, Pearson R, Cutts J, Seed C, Scott N, Hoad V, Dietze P, Wilson D, Maher L, Thompson A, Farrell M, Harrod M, Caris S, Pink J, Kotsiou G, et al. Blood donation amongst people who inject drugs in Australia: research supporting policy change. Vox Sanguinis. PMID 32023663 DOI: 10.1111/Vox.12891  1
2020 Xiao Y, van Gemert C, Howell J, Adamson E, Towell V, Cowie BC, Thompson AJ, Hellard M. 'Think Hep B' in primary care: A before-and-after evaluation of a self-guided learning package. Australian Journal of General Practice. 49: 66-69. PMID 32008273 DOI: 10.31128/AJGP-10-18-4739  1
2020 Hart W, Richardson R, Kameneva T, Thompson A, Wise AK, Fallon JB, Stoddart PR, Needham K. Combined optogenetic and electrical stimulation of auditory neurons increases effective stimulation frequency - An in vitro study. Journal of Neural Engineering. PMID 31923907 DOI: 10.1088/1741-2552/Ab6A68  1
2019 Bhagwan JR, Collins E, Mosqueira D, Bakar M, Johnson BB, Thompson A, Smith JGW, Denning C. Variable expression and silencing of CRISPR-Cas9 targeted transgenes identifies the locus as not an entirely safe harbour. F1000research. 8: 1911. PMID 32789000 DOI: 10.12688/F1000Research.19894.1  0.01
2019 Palmer AY, Wade AJ, Draper B, Howell J, Doyle JS, Petrie D, Thompson AJ, Wilson DP, Hellard ME, Scott N. A cost-effectiveness analysis of primary versus hospital-based specialist care for direct acting antiviral hepatitis C treatment. The International Journal On Drug Policy. 76: 102633. PMID 31869656 DOI: 10.1016/j.drugpo.2019.102633  1
2019 Xiao Y, Howell J, van Gemert C, Thompson AJ, Seaman CP, McCulloch K, Scott N, Hellard ME. Enhancing the hepatitis B care cascade in Australia: a cost-effectiveness model. Journal of Viral Hepatitis. PMID 31856377 DOI: 10.1111/jvh.13252  1
2019 Langley RJ, Dryden C, Westwood J, Anderson E, Thompson A, Urquhart D. Once daily combined inhaled steroid and ultra long-acting bronchodilator prescribing in pediatric asthma: a dual Center retrospective cohort study. The Journal of Asthma : Official Journal of the Association For the Care of Asthma. 1-2. PMID 31847644 DOI: 10.1080/02770903.2019.1702674  0.01
2019 French J, van der Mei I, Simpson S, Ng J, Angus P, Lubel J, Nicoll A, Sood S, Roberts SK, Kemp W, Arachchi N, Dev A, Thompson A, Gow PJ. Increasing Prevalence of Primary Biliary Cholangitis in Victoria, Australia. Journal of Gastroenterology and Hepatology. PMID 31693755 DOI: 10.1111/Jgh.14924  1
2019 Alghamdi A, Cook E, Carlton E, Siriwardena A, Hann M, Thompson A, Foulkes A, Phillips J, Cooper J, Bell S, Kirby K, Rosser A, Body R. PRe-hospital Evaluation of Sensitive TrOponin (PRESTO) Study: multicentre prospective diagnostic accuracy study protocol. Bmj Open. 9: e032834. PMID 31662404 DOI: 10.1136/Bmjopen-2019-032834  1
2019 Papaluca TJ, Tambakis G, Iser D, Thompson AJ. Effective prison-based treatment and linkage to care after release. The Lancet. Infectious Diseases. 19: 1171. PMID 31657780 DOI: 10.1016/S1473-3099(19)30536-5  1
2019 Dore GJ, Feld JJ, Thompson A, Martinello M, Muir AJ, Agarwal K, Müllhaupt B, Wedemeyer H, Lacombe K, Matthews GV, Schultz M, Klein M, Hezode C, Estivill Mercade G, Kho D, et al. Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial. Journal of Hepatology. PMID 31655134 DOI: 10.1016/J.Jhep.2019.10.010  1
2019 Tran S, Bennett G, Richmond J, Nguyen T, Ryan M, Hong T, Howell J, Demediuk B, Desmond P, Bell S, Thompson A. 'Teach-back' is a simple communication tool that improves disease knowledge in people with chronic hepatitis B - a pilot randomized controlled study. Bmc Public Health. 19: 1355. PMID 31647001 DOI: 10.1186/S12889-019-7658-4  1
2019 Papaluca T, O'Keefe J, Bowden S, Doyle JS, Stoove M, Hellard M, Thompson AJ. Prevalence of baseline HCV NS5A resistance associated substitutions in genotype 1a, 1b and 3 infection in Australia. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 120: 84-87. PMID 31606586 DOI: 10.1016/j.jcv.2019.09.011  1
2019 Scott N, Wilson DP, Thompson AJ, Barnes E, El-Sayed M, Benzaken AS, Drummer HE, Hellard ME. The case for a universal hepatitis C vaccine to achieve hepatitis C elimination. Bmc Medicine. 17: 175. PMID 31530275 DOI: 10.1186/s12916-019-1411-9  1
2019 Basnayake C, Kamm MA, Salzberg M, Khera A, Liew D, Burrell K, Wilson-O'Brien A, Stanley A, Talley NJ, Thompson AJ. Defining optimal care for functional gut disorders - Multi-disciplinary versus standard care: A randomized controlled trial protocol. Contemporary Clinical Trials. 105828. PMID 31437539 DOI: 10.1016/J.Cct.2019.105828  1
2019 Basnayake C, Kamm MA, Salzberg MR, Wilson-O'Brien A, Stanley A, Thompson AJ. Delivery of Care for Functional Gastrointestinal Disorders: A Systematic Review. Journal of Gastroenterology and Hepatology. PMID 31411755 DOI: 10.1111/Jgh.14830  1
2019 Papaluca T, Sinclair M, Gow P, Pianko S, Sievert W, Arachchi N, Cameron K, Bowden S, O'Keefe J, Doyle J, Stoove M, Hellard M, Iser D, Thompson A. Retreatment with Elbasvir, Grazoprevir, Sofosbuvir +/- Ribavirin is effective for GT3 and GT1/4/6 HCV infection after relapse. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 31355968 DOI: 10.1111/Liv.14201  1
2019 Hutton J, Doyle J, Zordan R, Weiland T, Cocco A, Howell J, Iser S, Snell J, Fry S, New K, Sloane R, Jarman M, Phan D, Tran S, Pedrana A, ... ... Thompson A, et al. Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department. The International Journal On Drug Policy. PMID 31351752 DOI: 10.1016/J.Drugpo.2019.06.021  1
2019 Strasser SI, Thompson AJ, Roberts SK, George J. Clinical Cases in Hepatitis: Towards improving liver disease management in Australia. Journal of Gastroenterology and Hepatology. 34: 5-15. PMID 31282011 DOI: 10.1111/jgh.14720  1
2019 Sasadeusz J, Grigg A, Hughes PD, Lee Lim S, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, et al. Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents. Clinics in Liver Disease. 23: 521-534. PMID 31266625 DOI: 10.1016/J.Cld.2019.04.012  1
2019 Sasadeusz J, Grigg A, Hughes PD, Lim SL, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, et al. Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor Malignancies. Clinics in Liver Disease. 23: 511-519. PMID 31266624 DOI: 10.1016/J.Cld.2019.04.011  1
2019 Sasadeusz J, Grigg A, Hughes PD, Lee Lim S, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, et al. Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Transplant Recipients. Clinics in Liver Disease. 23: 493-509. PMID 31266623 DOI: 10.1016/J.Cld.2019.04.010  1
2019 Sasadeusz J, Grigg A, Hughes PD, Lee Lim S, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, et al. Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and Immunology. Clinics in Liver Disease. 23: 487-492. PMID 31266622 DOI: 10.1016/J.Cld.2019.04.009  1
2019 Wade AJ, Doyle JS, Gane E, Stedman C, Draper B, Iser D, Roberts SK, Kemp W, Petrie D, Scott N, Higgs P, Agius PA, Roney J, Stothers L, Thompson AJ, et al. Outcomes of treatment for hepatitis C in primary care compared to hospital-based care: a randomised controlled trial in people who inject drugs. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31233117 DOI: 10.1093/cid/ciz546  1
2019 Thompson AJ, Buchan S, Carr B, Poling C, Hayes M, Fernando UP, Kaesler A, Schlanstein P, Hesselmann F, Arens J, Potkay JA, Rojas-Pena A, Bartlett RH, Hirschl RB. Low-Resistance, Concentric-Gated Pediatric Artificial Lung for End-Stage Lung Failure. Asaio Journal (American Society For Artificial Internal Organs : 1992). PMID 31192843 DOI: 10.1097/Mat.0000000000001018  1
2019 Williams B, Howell J, Doyle J, Thompson AJ, Draper B, Layton C, Latham N, Bramwell F, Membrey D, Mcpherson M, Roney J, Stoové M, Hellard ME, Pedrana A. Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study. The International Journal On Drug Policy. PMID 31129023 DOI: 10.1016/j.drugpo.2019.05.012  1
2019 Doyle J, Raggatt M, Slavin M, McLachlan SA, Strasser SI, Sasadeusz JJ, Howell J, Hajkowicz K, Nandurkar H, Johnston A, Bak N, Thompson AJ. Hepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statement. The Medical Journal of Australia. PMID 31104328 DOI: 10.5694/mja2.50160  1
2019 Fehily SR, Papaluca T, Thompson AJ. Long-Term Impact of Direct-Acting Antiviral Agent Therapy in HCV Cirrhosis: Critical Review. Seminars in Liver Disease. PMID 31041785 DOI: 10.1055/s-0039-1685538  1
2019 Thompson AJ, Sutton M, Payne K. Estimating Joint Health Condition Utility Values. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 22: 482-490. PMID 30975400 DOI: 10.1016/j.jval.2018.09.2843  1
2019 Papaluca T, Hellard ME, Thompson AJV, Lloyd AR. Scale-up of hepatitis C treatment in prisons is key to national elimination. The Medical Journal of Australia. PMID 30968417 DOI: 10.5694/mja2.50140  1
2019 Doyle JS, Scott N, Sacks-Davis R, Pedrana AE, Thompson AJ, Hellard ME. Treatment access is only the first step to hepatitis C elimination: experience of universal anti-viral treatment access in Australia. Alimentary Pharmacology & Therapeutics. PMID 30908706 DOI: 10.1111/apt.15210  1
2019 Pavlovic V, Yang L, Chan HL, Hou J, Janssen HL, Kao JH, Lampertico P, Peng CY, Piratvisuth T, Thompson AJ, Wedemeyer H, Wei L, Wat C. Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: a systematic review and meta-analysis of individual participant data. Antiviral Therapy. PMID 30865588 DOI: 10.3851/IMP3304  1
2019 Latham NH, Pedrana A, Doyle JS, Howell J, Williams B, Higgs P, Thompson AJ, Hellard ME. Community-based, point-of-care hepatitis C testing: perspectives and preferences of people who inject drugs. Journal of Viral Hepatitis. PMID 30801881 DOI: 10.1111/jvh.13087  1
2019 Papaluca T, McDonald L, Craigie A, Gibson A, Desmond P, Wong D, Winter R, Scott N, Howell J, Doyle J, Pedrana A, Lloyd A, Stoove M, Hellard M, Iser D, ... Thompson A, et al. Outcomes of treatment for hepatitis C in prisoners using a nurse-led, state-wide model of care. Journal of Hepatology. PMID 30654067 DOI: 10.1016/J.Jhep.2019.01.012  1
2018 Khera AJ, Chase JW, Salzberg M, Thompson AJV, Kamm MA. Gut-Directed Pelvic Floor Behavioral Treatment for Fecal Incontinence and Constipation in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. PMID 30452638 DOI: 10.1093/Ibd/Izy344  1
2018 Song Y, Nigro J, Yu L, Congiu M, Skinner N, Thompson A, Visvanathan K. Secreted and intracellular cytokines are complementary measures for human monocytes treated with Toll-like receptor agonists. Journal of Immunological Methods. PMID 30395817 DOI: 10.1016/J.Jim.2018.11.003  1
2018 Asgari S, Chaturvedi N, Scepanovic P, Hammer C, Semmo N, Giostra E, Müllhaupt B, Angus P, Thompson AJ, Moradpour D, Fellay J. Human genomics of acute liver failure due to hepatitis B virus infection: an exome sequencing study in liver transplant recipients. Journal of Viral Hepatitis. PMID 30315682 DOI: 10.1111/jvh.13019  1
2018 Hong TP, Gow PJ, Fink M, Dev A, Roberts SK, Nicoll A, Lubel JS, Kronborg I, Arachchi N, Ryan M, Kemp WW, Knight V, Sundararajan V, Desmond P, Thompson AJ, et al. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study. The Medical Journal of Australia. 209: 348-354. PMID 30309301 DOI: 10.5694/mja18.00373  1
2018 O'Leary DA, Cropp E, Isaac D, Desmond PV, Bell S, Nguyen T, Wong D, Howell J, Richmond J, O'Neill J, Thompson AJ. "B in IT" - a community-based model for the management of hepatitis B patients in primary care clinics using a novel web-based clinical tool. Hepatology, Medicine and Policy. 3: 1. PMID 30288324 DOI: 10.1186/s41124-017-0031-2  1
2018 Papaluca T, Thompson AJ. Patient-centred care for cirrhosis: a key role for chronic disease management. The Medical Journal of Australia. 209: 296-297. PMID 30257630 DOI: 10.5694/mja18.00754  1
2018 Howell J, Pedrana A, Cowie BC, Doyle J, Getehun A, Ward J, Gane E, Cunningham C, Wallace J, Lee A, Malani J, Thompson A, Hellard ME. Aiming for the elimination of viral hepatitis in Australia, New Zealand, the Pacific Islands and Territories: where are we now and barriers to meeting WHO targets by 2030. Journal of Gastroenterology and Hepatology. PMID 30151932 DOI: 10.1111/Jgh.14457  1
2018 Thompson AJ, Ma LJ, Plegue TJ, Potkay JA. Design Analysis and Optimization of a Single Layer PDMS Microfluidic Artificial Lung. Ieee Transactions On Bio-Medical Engineering. PMID 30139043 DOI: 10.1109/Tbme.2018.2866782  1
2018 Davison NJ, Thompson AJ, Turner AJ, Longworth L, McElhone K, Griffiths CEM, Payne K. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 21: 1010-1018. PMID 30098665 DOI: 10.1016/j.jval.2017.10.024  1
2018 Basnayake C, Kamm MA, Salzberg M, Stanley A, Khera A, Burrell K, Wilson-O'Brien A, Hebbard G, Thompson AJ. Outcome of hospital outpatient treatment of functional gastrointestinal disorders. Internal Medicine Journal. PMID 30091176 DOI: 10.1111/Imj.14067  1
2018 Scott N, Sacks-Davis R, Pedrana A, Doyle J, Thompson A, Hellard M. Eliminating hepatitis C: the importance of frequent testing of people who inject drugs in high prevalence settings. Journal of Viral Hepatitis. PMID 30047625 DOI: 10.1111/Jvh.12975  1
2018 Thompson AJ, Dearani JA, Johnson JN, Schaff HV, Towe EC, Palfreeman J, Wackel PL, Cetta F. What is the role of apical ventriculotomy in children and young adults with hypertrophic cardiomyopathy? Congenital Heart Disease. PMID 30019505 DOI: 10.1111/chd.12618  1
2018 Wei L, Wedemeyer H, Liaw YF, Chan HL, Piratvisuth T, Marcellin P, Jia J, Tan D, Chow WC, Brunetto MR, Diago M, Gurel S, Morozov V, He H, Zhu Y, ... ... Thompson AJ, et al. No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B. Plos One. 13: e0199198. PMID 30016335 DOI: 10.1371/journal.pone.0199198  1
2018 Wade AJ, Doyle JS, Gane E, Stedman C, Draper B, Iser D, Roberts SK, Kemp W, Petrie D, Scott N, Higgs P, Agius PA, Roney J, Stothers L, Thompson AJ, et al. Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial. Trials. 19: 383. PMID 30012192 DOI: 10.1186/s13063-018-2768-3  1
2018 Nelson B, Amminger GP, Yuen HP, Markulev C, Lavoie S, Schäfer MR, Hartmann JA, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger G, Chen EYH, de Haan L, Nieman DH, ... ... Thompson A, et al. NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical course. Npj Schizophrenia. 4: 11. PMID 29941938 DOI: 10.1038/s41537-018-0052-x  0.01
2018 Thompson AJ, Power M, Yang GZ. Micro-scale fiber-optic force sensor fabricated using direct laser writing and calibrated using machine learning. Optics Express. 26: 14186-14200. PMID 29877460  1
2018 Bourlière M, Gordon SC, Schiff ER, Tran TT, Ravendhran N, Landis CS, Hyland RH, Stamm LM, Zhang J, Dvory-Sobol H, Subramanian GM, Brainard DM, McHutchison JG, Serfaty L, Thompson AJ, et al. Deferred treatment with sofosbuvir-velpatasvir-voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1. The Lancet. Gastroenterology & Hepatology. PMID 29859740 DOI: 10.1016/S2468-1253(18)30118-3  1
2018 Gavan SP, Thompson AJ, Payne K. The economic case for precision medicine. Expert Review of Precision Medicine and Drug Development. 3: 1-9. PMID 29682615 DOI: 10.1080/23808993.2018.1421858  1
2018 Vysniauskas A, Lopez Duarte I, Thompson AJ, Bull JA, Kuimova M. Surface functionalisation with viscosity-sensitive BODIPY molecular rotor. Methods and Applications in Fluorescence. PMID 29611817 DOI: 10.1088/2050-6120/aabb2c  0.01
2018 Goutzamanis S, Doyle JS, Thompson A, Dietze P, Hellard M, Higgs P. Experiences of liver health related uncertainty and self-reported stress among people who inject drugs living with hepatitis C virus: a qualitative study. Bmc Infectious Diseases. 18: 151. PMID 29609552 DOI: 10.1186/S12879-018-3057-1  1
2018 Smith ZK, Thompson AJ, Hutcheson JP, Nichols WT, Johnson BJ. Evaluation of Coated Steroidal Implants Containing Trenbolone Acetate and Estradiol-17β on Live Performance, Carcass Traits, and Sera Metabolites in Finishing Steers. Journal of Animal Science. PMID 29534183 DOI: 10.1093/jas/sky095  1
2018 Power M, Thompson AJ, Anastasova S, Yang GZ. A Monolithic Force-Sensitive 3D Microgripper Fabricated on the Tip of an Optical Fiber Using 2-Photon Polymerization. Small (Weinheim An Der Bergstrasse, Germany). PMID 29479810 DOI: 10.1002/smll.201703964  1
2018 Wong D, Littlejohn M, Edwards R, Jackson K, Revill P, Gaggar A, Kitrinos K, Subramanian M, Marcellin P, Buti M, Janssen H, Gane E, Locarnini S, Thompson A. ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis B. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 29427368 DOI: 10.1111/Liv.13716  1
2018 Younossi ZM, Stepanova M, Jacobson IM, Asselah T, Gane EJ, Lawitz E, Foster GR, Roberts SK, Thompson AJ, Willems BE, Welzel TM, Pearlman B, Younossi I, Racila A, Henry L. Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3. Alimentary Pharmacology & Therapeutics. 47: 259-267. PMID 29181842 DOI: 10.1111/apt.14423  1
2017 Stepanova M, Thompson A, Doyle J, Younossi I, de Avila L, Younossi ZM. Hepatitis C Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment with Interferon-Free Regimens. The Journal of Infectious Diseases. PMID 29293991 DOI: 10.1093/Infdis/Jix681  1
2017 Plegue TJ, Kovach KM, Thompson AJ, Potkay JA. Stability of Polyethylene Glycol and Zwitterionic Surface Modifications in PDMS Microfluidic Flow Chambers. Langmuir : the Acs Journal of Surfaces and Colloids. PMID 29231737 DOI: 10.1021/Acs.Langmuir.7B03095  1
2017 McCaughan GW, Thwaites PA, Roberts SK, Strasser SI, Mitchell J, Morales B, Mason S, Gow P, Wigg A, Tallis C, Jeffrey G, George J, Thompson AJ, Parker FC, Angus PW, et al. Sofosbuvir and daclatasvir therapy in patients with hepatitis C-related advanced decompensated liver disease (MELD ≥ 15). Alimentary Pharmacology & Therapeutics. PMID 29205432 DOI: 10.1111/apt.14404  1
2017 Thompson AJ, Hughes M, Anastasova S, Conklin LS, Thomas T, Leggett C, Faubion WA, Miller TJ, Delaney P, Lacombe F, Loiseau S, Meining A, Richards-Kortum R, Tearney GJ, Kelly P, et al. Position paper: The potential role of optical biopsy in the study and diagnosis of environmental enteric dysfunction. Nature Reviews. Gastroenterology & Hepatology. PMID 29139480 DOI: 10.1038/Nrgastro.2017.147  1
2017 Sun L, Kaesler A, Fernando P, Thompson AJ, Toomasian JM, Bartlett RH. CO2 clearance by membrane lungs. Perfusion. 267659117736379. PMID 29090614 DOI: 10.1177/0267659117736379  1
2017 Chen Yi Mei SLG, Thompson AJ, Christensen B, Cunningham G, McDonald L, Bell S, Iser D, Nguyen T, Desmond PV. Sustained virological response halts fibrosis progression: A long-term follow-up study of people with chronic hepatitis C infection. Plos One. 12: e0185609. PMID 29065124 DOI: 10.1371/journal.pone.0185609  1
2017 Wong D, Littlejohn M, Yuen L, Jackson K, Mason H, Bayliss J, Rosenberg G, Gaggar A, Kitrinos K, Subramanian M, Marcellin P, Buti M, Janssen HLA, Gane E, Locarnini S, ... Thompson A, et al. HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg-positive chronic hepatitis B patients. Alimentary Pharmacology & Therapeutics. PMID 29023803 DOI: 10.1111/apt.14362  1
2017 Scott N, Doyle JS, Wilson DP, Wade A, Howell J, Pedrana A, Thompson A, Hellard ME. Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade. The International Journal On Drug Policy. PMID 28797497 DOI: 10.1016/J.Drugpo.2017.07.006  1
2017 Quinn B, Seed C, Keller A, Maher L, Wilson D, Farrell M, Caris S, Williams J, Madden A, Thompson A, Pink J, Hellard ME. Re-examining blood donor deferral criteria relating to injecting drug use. The International Journal On Drug Policy. 48: 9-17. PMID 28666205 DOI: 10.1016/J.Drugpo.2017.05.058  1
2017 Fernando UP, Thompson AJ, Potkay J, Cheriyan H, Toomasian J, Kaesler A, Schlanstein P, Arens J, Hirschl RB, Bull JL, Bartlett RH. A Membrane Lung Design Based on Circular Blood Flow Paths. Asaio Journal (American Society For Artificial Internal Organs : 1992). PMID 28665829 DOI: 10.1097/Mat.0000000000000616  1
2017 Reddy KR, Osinusi A, Thompson AJ. The Need for Appropriate Comparisons: A Response to Ravi et al. Gastroenterology. PMID 28579274 DOI: 10.1053/j.gastro.2017.03.074  0.01
2017 Gane EJ, Shiffman ML, Etzkorn K, Morelli G, Stedman C, Davis MN, Hinestrosa F, Dvory-Sobol H, Huang KC, Osinusi A, McNally J, Brainard DM, McHutchison JG, Thompson AJ, Sulkowski MS, et al. Sofosbuvir-velpatasvir with ribavirin for 24 weeks in HCV patients previously treated with a direct-acting antiviral regimen. Hepatology (Baltimore, Md.). PMID 28498551 DOI: 10.1002/hep.29256  1
2017 Lubel J, Strasser S, Stuart KA, Dore G, Thompson A, Pianko S, Bollipo S, Mitchell JL, Fragomeli V, Jones T, Chivers S, Gow P, Iser D, Levy M, Tse E, et al. Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL study. Antiviral Therapy. PMID 28422043 DOI: 10.3851/Imp3168  1
2017 Howell J, Thompson AJ. Hepatocellular carcinoma post-SVR - leave no-one behind. Gastroenterology. PMID 28363642 DOI: 10.1053/j.gastro.2017.03.025  1
2017 Jacobson IM, Washington MK, Buti M, Thompson A, Afdhal N, Flisiak R, Akarca US, Tchernev KG, Flaherty JF, Schall RA, Myers RP, Subramanian GM, McHutchison JG, Younossi Z, Marcellin P, et al. Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 28215615 DOI: 10.1016/J.Cgh.2017.01.032  1
2016 Goutzamanis S, Doyle J, Thompson A, Hellard M, Higgs P. Direct-acting antiviral treatment for HCV. The Lancet. Infectious Diseases. 16: 1325-1326. PMID 27998585 DOI: 10.1016/S1473-3099(16)30403-0  1
2016 Lim L, Thompson A, Patterson S, George J, Strasser S, Lee A, Sievert W, Nicoll A, Desmond P, Roberts S, Marion K, Bowden S, Locarnini S, Angus P. Five year efficacy and safety of tenofovir-based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapy. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 27896895 DOI: 10.1111/Liv.13331  1
2016 Thompson A, Locarnini S, Revill P. Reply: 'More viral mutants, less HBsAg clearance? One size may not fit all'. Gut. PMID 27884921 DOI: 10.1136/Gutjnl-2016-313287  1
2016 Thompson AJ, Bowden DS. Vidal LL, et al. NS3 protease polymorphisms and genetic barrier to drug resistance of distinct HCV genotypes from worldwide treatment-naive subjects. JVH, 2016, 23(11): 840-849. Journal of Viral Hepatitis. 23: 838-839. PMID 27804238 DOI: 10.1111/jvh.12570  1
2016 Foster GR, Chayama K, Chuang WL, Fainboim H, Farkkila M, Gadano A, Gaeta GB, Hézode C, Inada Y, Heo J, Kumada H, Lu SN, Marcellin P, Moreno C, Roberts SK, ... Thompson AJ, et al. A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3. Springerplus. 5: 1365. PMID 27588258 DOI: 10.1186/s40064-016-2920-z  1
2016 McElroy HJ, Roberts SK, Thompson AJ, Angus PW, McKenna SJ, Warren E, Musgrave S. Medical resource utilization and costs among Australian patients with genotype 1 chronic hepatitis C: results of a retrospective observational study. Journal of Medical Economics. 1-24. PMID 27552282 DOI: 10.1080/13696998.2016.1227827  1
2016 Bayliss J, Yuen L, Rosenberg G, Wong D, Littlejohn M, Jackson K, Gaggar A, Kitrinos KM, Subramanian GM, Marcellin P, Buti M, Janssen HL, Gane E, Sozzi V, Colledge D, ... Thompson A, et al. Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B. Gut. PMID 27534671 DOI: 10.1136/Gutjnl-2015-309300  1
2016 Allard N, Dev A, Dwyer J, Srivatsa G, Thompson A, Cowie B. Factors associated with poor adherence to antiviral treatment for hepatitis B. Journal of Viral Hepatitis. PMID 27502689 DOI: 10.1111/jvh.12582  1
2016 Iglesias CP, Thompson A, Rogowski WH, Payne K. Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic Evaluations. Pharmacoeconomics. PMID 27364887 DOI: 10.1007/S40273-016-0425-9  1
2016 Chen Yi Mei SL, Burchell J, Skinner N, Millen R, Matthews G, Hellard M, Dore GJ, Desmond P, Sundararajan V, Thompson A, Visvanathan K, Sasadeusz J. Toll-like receptor expression and signalling in peripheral blood mononuclear cells correlate with clinical outcomes in acute hepatitis C infection. The Journal of Infectious Diseases. PMID 27284092 DOI: 10.1093/infdis/jiw235  1
2016 Petersen J, Thompson AJ, Levrero M. "Aiming for cure in HBV and HDV infection". Journal of Hepatology. PMID 27270043 DOI: 10.1016/j.jhep.2016.05.043  0.01
2016 Betz-Stablein BD, Töpfer A, Littlejohn M, Yuen L, Colledge D, Sozzi V, Angus P, Thompson A, Revill P, Beerenwinkel N, Warner N, Luciani F. Single-molecule sequencing reveals complex genomic variation of hepatitis B virus during 15 years of chronic infection following liver transplantation. Journal of Virology. PMID 27252524 DOI: 10.1128/Jvi.00243-16  1
2016 Hajarizadeh B, Grebely J, McManus H, Estes C, Razavi H, Gray RT, Alavi M, Amin J, McGregor S, Sievert W, Thompson A, Dore GJ. Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment. Journal of Gastroenterology and Hepatology. PMID 27197716 DOI: 10.1111/Jgh.13453  1
2016 Scott N, McBryde ES, Thompson A, Doyle JS, Hellard ME. Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model. Gut. PMID 27196586 DOI: 10.1136/Gutjnl-2016-311504  1
2016 Thompson AJ. Australian recommendations for the management of hepatitis C virus infection: a consensus statement. The Medical Journal of Australia. 204: 268-72. PMID 27078601 DOI: 10.5694/mja16.00106  0.01
2016 Doyle JS, Thompson AJ. Local transmission of hepatitis E virus in Australia: implications for clinicians and public health. The Medical Journal of Australia. 204: 254. PMID 27078590 DOI: 10.5694/mja16.00167  1
2016 Asselah T, Thompson AJ, Flisiak R, Romero-Gomez M, Messinger D, Bakalos G, Shiffman ML. A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin. Plos One. 11: e0150569. PMID 26991780 DOI: 10.1371/journal.pone.0150569  1
2016 Brouwer WP, Chan HL, Brunetto MR, Martinot-Peignoux M, Arends P, Cornberg M, Cherubini B, Thompson AJ, Liaw YF, Marcellin P, Janssen HL, Hansen BE. Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-Term Follow-up. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 26872398 DOI: 10.1016/j.cgh.2016.01.019  1
2016 Thompson AJ, Cannon BC, Wackel PL, Horner JM, Ackerman MJ, O'Leary PW, Eidem BW, Johnson JN. Electrocardiographic abnormalities in elite high school athletes: comparison to adolescent hypertrophic cardiomyopathy. British Journal of Sports Medicine. 50: 105-10. PMID 26729893 DOI: 10.1136/bjsports-2015-094880  1
2016 Thompson AJ, Koziej L, Williams HD, Elson DS, Yang GZ. Towards optical fibre based Raman spectroscopy for the detection of surgical site infection Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9704. DOI: 10.1117/12.2212769  1
2015 Fish MB, Thompson AJ, Fromen CA, Eniola-Adefeso O. Emergence and Utility of Nonspherical Particles in Biomedicine. Industrial & Engineering Chemistry Research. 54: 4043-4059. PMID 27182109 DOI: 10.1021/ie504452j  1
2015 Thompson AJ, Holmes JA. Treating hepatitis C - what's new? Australian Prescriber. 38: 191-7. PMID 26843711  1
2015 Holmes JA, Thompson AJ. Interferon-free combination therapies for the treatment of hepatitis C: current insights. Hepatic Medicine : Evidence and Research. 7: 51-70. PMID 26586968 DOI: 10.2147/HMER.S55864  1
2015 McElroy H, Roberts S, Thompson A, Angus P, McKenna SJ, Warren E, Musgrave S. Medical Resource Utilisation of Australian Patients With Genotype 1 Chronic Hepatitis C: A Retrospective Observational Study. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 18: A632. PMID 26533549 DOI: 10.1016/J.Jval.2015.09.2238  1
2015 Hellard M, Thompson A, Scott N, Iser D, Doyle JS. Cost-effectiveness of treating chronic hepatitis C virus with direct-acting antivirals in people who inject drugs in Australia. Journal of Gastroenterology and Hepatology. PMID 26514998 DOI: 10.1111/jgh.13223  1
2015 Visvanathan K, Lang T, Ryan K, Wilson R, Skinner NA, Thompson AJ, Ahn SH, Weilert F, Abbott W, Gane E, Colledge D, Li K, Locarnini S, Mansell A, Revill PA. Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients. Journal of Viral Hepatitis. PMID 26436722 DOI: 10.1111/jvh.12477  1
2015 Hong T, Gow P, Fink M, Dev A, Roberts S, Nicoll A, Lubel J, Kronborg I, Arachchi N, Ryan M, Kemp W, Knight V, Farrugia H, Thursfield V, Desmond P, Thompson A, et al. Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed. Hepatology (Baltimore, Md.). PMID 26435297 DOI: 10.1002/hep.28267  1
2015 Ding NS, Nguyen T, Iser DM, Hong T, Flanagan E, Wong A, Luiz L, Tan JY, Fulforth J, Holmes J, Ryan M, Bell SJ, Desmond PV, Roberts SK, Lubel J, ... Thompson AJ, et al. Liver stiffness plus platelet count can be used to exclude high risk oesophageal varices. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 26212020 DOI: 10.1111/liv.12916  1
2015 Hellard M, McBryde E, Sacks Davis R, Rolls DA, Higgs P, Aitken C, Thompson A, Doyle J, Pattison P, Robins G. Hepatitis C transmission and treatment as prevention - The role of the injecting network. The International Journal On Drug Policy. PMID 26072105 DOI: 10.1016/J.Drugpo.2015.05.006  1
2015 Holmes JA, Congiu M, Bonanzinga S, Sandhu MK, Kia YH, Bell SJ, Nguyen T, Iser DM, Visvanathan K, Sievert W, Bowden DS, Desmond PV, Thompson AJ. The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3. Alimentary Pharmacology & Therapeutics. PMID 26032235 DOI: 10.1111/apt.13263  1
2015 Sievert W, Razavi H, Thompson A, Zekry A, Dore GJ, Roberts SK. HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths. The Medical Journal of Australia. 202: 479. PMID 25971570 DOI: 10.5694/Mja15.00165  1
2015 Muir AJ, Poordad F, Lalezari J, Everson G, Dore GJ, Herring R, Sheikh A, Kwo P, Hézode C, Pockros PJ, Tran A, Yozviak J, Reau N, Ramji A, Stuart K, Thompson AJ, et al. Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis. Jama. 313: 1736-44. PMID 25942724 DOI: 10.1001/jama.2015.3868  1
2015 Thompson AJ, Eniola-Adefeso O. Dense nanoparticles exhibit enhanced vascular wall targeting over neutrally buoyant nanoparticles in human blood flow. Acta Biomaterialia. 21: 99-108. PMID 25870170 DOI: 10.1016/j.actbio.2015.04.005  1
2015 Bruno S, Thompson AJ, Critelli R, Crosignani A, Rossi S, De Lisi S, Cariani E, Zermiani P, Vaira V, Boccaccio V, Maisonneuve P, Villa E. Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort study. Antiviral Research. 113: 27-32. PMID 25446338 DOI: 10.1016/j.antiviral.2014.11.002  1
2015 Thompson AJ, Hagler DJ, Taggart NW. Transseptal puncture to facilitate device closure of "long-tunnel" patent foramen ovale. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. 85: 1053-7. PMID 25380406 DOI: 10.1002/ccd.25723  1
2015 Thompson A, Stringfellow L, Maclean M, MacLaren A, O’Gorman K. Puppets of necessity? Celebritisation in structured reality television Journal of Marketing Management. 31: 478-501. DOI: 10.1080/0267257X.2014.988282  1
2015 Wang H, Kirkham MJ, Watkins TR, Payzant EA, Salvador JR, Thompson AJ, Sharp J, Brown D, Miller D. Neutron and X-ray powder diffraction study of skutterudite thermoelectrics Powder Diffraction. 31: 16-22. DOI: 10.1017/S0885715615000937  1
2015 Brydegaard M, Thompson AJ, Andersson-Engels S, Bendsoe N, Svanberg K, Svanberg S. Complete parameterization of temporally and spectrally resolved laser induced fluorescence data with applications in bio-photonics Chemometrics and Intelligent Laboratory Systems. 142: 95-106. DOI: 10.1016/j.chemolab.2015.01.014  1
2014 Burns GS, Thompson AJ. Viral hepatitis B: Clinical and epidemiological characteristics Cold Spring Harbor Perspectives in Medicine. 4. PMID 25359547 DOI: 10.1101/cshperspect.a024935  1
2014 Namdee K, Thompson AJ, Golinski A, Mocherla S, Bouis D, Eniola-Adefeso O. In vivo evaluation of vascular-targeted spheroidal microparticles for imaging and drug delivery application in atherosclerosis. Atherosclerosis. 237: 279-86. PMID 25286447 DOI: 10.1016/j.atherosclerosis.2014.09.025  1
2014 Sobczynski DJ, Charoenphol P, Heslinga MJ, Onyskiw PJ, Namdee K, Thompson AJ, Eniola-Adefeso O. Plasma protein corona modulates the vascular wall interaction of drug carriers in a material and donor specific manner. Plos One. 9: e107408. PMID 25229244 DOI: 10.1371/Journal.Pone.0107408  1
2014 Sievert W, Razavi H, Estes C, Thompson AJ, Zekry A, Roberts SK, Dore GJ. Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia. Journal of Gastroenterology and Hepatology. 29: 1-9. PMID 25055928 DOI: 10.1111/jgh.12677  1
2014 Flanagan E, Thompson AJ, Colledge D, Edwards R, Littlejohn M, Walsh R, Warner N, Bowden DS, Iser DM. A novel hepatitis B virus S gene insertion associated with reduced humoral immunity and diagnostic escape. Internal Medicine Journal. 44: 709-10. PMID 25041776 DOI: 10.1111/imj.12465  1
2014 Jegaskanda S, Ahn SH, Skinner N, Thompson AJ, Ngyuen T, Holmes J, De Rose R, Navis M, Winnall WR, Kramski M, Bernardi G, Bayliss J, Colledge D, Sozzi V, Visvanathan K, et al. Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen. Journal of Virology. 88: 10412-20. PMID 24872585 DOI: 10.1128/JVI.00111-14  1
2014 Beard MR, Ffrench R, Gowans EJ, Helbig KJ, Eyre NM, Douglas MM, Grebely J, Ahlenstiel G, Locarnini S, George J, Shackel NA, White PA, Thompson AJ, Drummer HE. A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses. Gastroenterology. 147: e1-4. PMID 24861641 DOI: 10.1053/j.gastro.2014.05.022  1
2014 Di Angelantonio E, Gao P, Khan H, Butterworth AS, Wormser D, Kaptoge S, Kondapally Seshasai SR, Thompson A, Sarwar N, Willeit P, Ridker PM, Barr EL, Khaw KT, Psaty BM, et al. Glycated hemoglobin measurement and prediction of cardiovascular disease. Jama. 311: 1225-33. PMID 24668104 DOI: 10.1001/Jama.2014.1873  1
2014 Coda S, Thompson AJ, Kennedy GT, Roche KL, Ayaru L, Bansi DS, Stamp GW, Thillainayagam AV, French PM, Dunsby C. Fluorescence lifetime spectroscopy of tissue autofluorescence in normal and diseased colon measured ex vivo using a fiber-optic probe. Biomedical Optics Express. 5: 515-38. PMID 24575345 DOI: 10.1364/BOE.5.000515  1
2014 Holmes JA, Roberts SK, Ali RJ, Dore GJ, Sievert W, McCaughan GW, Crawford DH, Cheng WS, Weltman MD, Bonanzinga S, Visvanathan K, Sundararajan V, Desmond PV, Bowden DS, Matthews GV, Thompson AJ, et al. ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response. Hepatology (Baltimore, Md.). 59: 2152-60. PMID 24449403 DOI: 10.1002/hep.27022  1
2014 Heslinga MJ, Willis GM, Sobczynski DJ, Thompson AJ, Eniola-Adefeso O. One-step fabrication of agent-loaded biodegradable microspheroids for drug delivery and imaging applications. Colloids and Surfaces. B, Biointerfaces. 116: 55-62. PMID 24441181 DOI: 10.1016/J.Colsurfb.2013.12.054  1
2014 Thompson AJ, Newman WG, Elliott RA, Roberts SA, Tricker K, Payne K. The cost-effectiveness of a pharmacogenetic test: a trial-based evaluation of TPMT genotyping for azathioprine. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: 22-33. PMID 24438714 DOI: 10.1016/j.jval.2013.10.007  1
2014 Hassawi M, Shestakova EA, Fournier M, Lebert-Ghali CÉ, Vaisson G, Frison H, Sinnett D, Vidal R, Thompson A, Bijl JJ. Hoxa9 collaborates with E2A-PBX1 in mouse B cell leukemia in association with Flt3 activation and decrease of B cell gene expression. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 243: 145-58. PMID 23996689 DOI: 10.1002/Dvdy.24056  0.01
2014 Thompson AJ, Tang TYD, Herling TW, Che Hak CR, Mann S, Knowles TPJ, Kuimova MK. Quantitative sensing of microviscosity in protocells and amyloid materials using fluorescence lifetime imaging of molecular rotors Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8947. DOI: 10.1117/12.2037851  1
2014 Thompson AJ, Clark P, Aghemo A. Hepatitis C Virus Handbook of Pharmacogenomics and Stratified Medicine. 859-877. DOI: 10.1016/B978-0-12-386882-4.00037-2  1
2013 Thompson AJ, Mastria EM, Eniola-Adefeso O. The margination propensity of ellipsoidal micro/nanoparticles to the endothelium in human blood flow. Biomaterials. 34: 5863-71. PMID 23642534 DOI: 10.1016/j.biomaterials.2013.04.011  1
2013 Namdee K, Thompson AJ, Charoenphol P, Eniola-Adefeso O. Margination propensity of vascular-targeted spheres from blood flow in a microfluidic model of human microvessels. Langmuir : the Acs Journal of Surfaces and Colloids. 29: 2530-5. PMID 23363293 DOI: 10.1021/La304746P  1
2013 Holmes JA, Nguyen T, Ratnam D, Heerasing NM, Tehan JV, Bonanzinga S, Dev A, Bell S, Pianko S, Chen R, Visvanathan K, Hammond R, Iser D, Rusli F, Sievert W, ... ... Thompson AJ, et al. IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α. Journal of Gastroenterology and Hepatology. 28: 861-6. PMID 23301835 DOI: 10.1111/Jgh.12110  1
2013 Cheng Y, Guindon S, Rodrigo A, Wee LY, Inoue M, Thompson AJ, Locarnini S, Lim SG. Cumulative viral evolutionary changes in chronic hepatitis B virus infection precedes hepatitis B e antigen seroconversion. Gut. 62: 1347-55. PMID 23242209 DOI: 10.1136/gutjnl-2012-302408  1
2012 Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, Walker M, Thompson A, Sarwar N, Caslake M, Butterworth AS, Amouyel P, Assmann G, Bakker SJ, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. The New England Journal of Medicine. 367: 1310-20. PMID 23034020 DOI: 10.1056/Nejmoa1107477  1
2012 Di Angelantonio E, Gao P, Pennells L, Kaptoge S, Caslake M, Thompson A, Butterworth AS, Sarwar N, Wormser D, Saleheen D, Ballantyne CM, Psaty BM, Sundström J, Ridker PM, et al. Lipid-related markers and cardiovascular disease prediction. Jama. 307: 2499-506. PMID 22797450 DOI: 10.1001/Jama.2012.6571  1
2012 Lucas JE, Thompson JW, Dubois LG, McCarthy J, Tillmann H, Thompson A, Shire N, Hendrickson R, Dieguez F, Goldman P, Schwarz K, Patel K, McHutchison J, Moseley MA. Metaprotein expression modeling for label-free quantitative proteomics. Bmc Bioinformatics. 13: 74. PMID 22559859 DOI: 10.1186/1471-2105-13-74  1
2012 Clark PJ, Thompson AJ, Vock DM, Kratz LE, Tolun AA, Muir AJ, McHutchison JG, Subramanian M, Millington DM, Kelley RI, Patel K. Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner. Hepatology (Baltimore, Md.). 56: 49-56. PMID 22318926 DOI: 10.1002/Hep.25631  1
2012 Thompson AJ, Coda S, Sørensen MB, Kennedy G, Patalay R, Waitong-Brämming U, De Beule PA, Neil MA, Andersson-Engels S, Bendsøe N, French PM, Svanberg K, Dunsby C. In vivo measurements of diffuse reflectance and time-resolved autofluorescence emission spectra of basal cell carcinomas. Journal of Biophotonics. 5: 240-54. PMID 22308093 DOI: 10.1002/jbio.201100126  1
2012 Naggie S, Rallon NI, Benito JM, Morello J, Rodriguez-Novoa S, Clark PJ, Thompson AJ, Shianna KV, Vispo E, McHutchison JG, Goldstein DB, Soriano V. Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia in HIV/HCV-coinfected patients with all HCV genotypes. The Journal of Infectious Diseases. 205: 376-83. PMID 22158703 DOI: 10.1093/infdis/jir754  1
2012 Desmond CP, Gaudieri S, James IR, Pfafferott K, Chopra A, Lau GK, Audsley J, Day C, Chivers S, Gordon A, Revill PA, Bowden S, Ayres A, Desmond PV, Thompson AJ, et al. Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease. Journal of Virology. 86: 1181-92. PMID 22072755 DOI: 10.1128/JVI.05308-11  1
2012 Thompson AJ, Patel K, Chuang WL, Lawitz EJ, Rodriguez-Torres M, Rustgi VK, Flisiak R, Pianko S, Diago M, Arora S, Foster GR, Torbenson M, Benhamou Y, Nelson DR, Sulkowski MS, et al. Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3. Gut. 61: 128-34. PMID 21873466 DOI: 10.1136/gut.2010.236158  1
2012 Clark PJ, Thompson AJ. Host genomics and HCV treatment response Journal of Gastroenterology and Hepatology (Australia). 27: 212-222. DOI: 10.1111/j.1440-1746.2011.06918.x  1
2012 Thompson AJ, Clark PJ, Muir AJ, Sulkowski MS. Reply to "iL28B polymorphism and hepatitis C: A genetic marker of peginterferon-α sensitivity devoid from classical interferon-α side effects?" Journal of Hepatology. 56: 742-743. DOI: 10.1016/j.jhep.2011.08.011  1
2011 Thompson AJ, Locarnini SA, Beard MR. Resistance to anti-HCV protease inhibitors. Current Opinion in Virology. 1: 599-606. PMID 22440917 DOI: 10.1016/j.coviro.2011.10.001  1
2011 Cyr DD, Lucas JE, Thompson JW, Patel K, Clark PJ, Thompson A, Tillmann HL, McHutchison JG, Moseley MA, McCarthy JJ. Characterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C. Plos One. 6: e21854. PMID 21750736 DOI: 10.1371/Journal.Pone.0021854  1
2011 Thompson AJ, Paterson C, Neil MA, Dunsby C, French PM. Adaptive phase compensation for ultracompact laser scanning endomicroscopy. Optics Letters. 36: 1707-9. PMID 21540976  1
2011 Patel K, Lucas JE, Thompson JW, Dubois LG, Tillmann HL, Thompson AJ, Uzarski D, Califf RM, Moseley MA, Ginsburg GS, McHutchison JG, McCarthy JJ. High predictive accuracy of an unbiased proteomic profile for sustained virologic response in chronic hepatitis C patients. Hepatology (Baltimore, Md.). 53: 1809-18. PMID 21381069 DOI: 10.1002/Hep.24284  1
2011 Iser DM, Avihingsanon A, Wisedopas N, Thompson AJ, Boyd A, Matthews GV, Locarnini SA, Slavin J, Desmond PV, Lewin SR. Increased intrahepatic apoptosis but reduced immune activation in HIV-HBV co-infected patients with advanced immunosuppression. Aids (London, England). 25: 197-205. PMID 21076271 DOI: 10.1097/QAD.0b013e3283410ccb  1
2011 Clark PJ, Thompson AJ, McHutchison JG. IL28B genomic-based treatment paradigms for patients with chronic hepatitis C infection: The future of personalized HCV therapies American Journal of Gastroenterology. 106: 38-45. PMID 20924369 DOI: 10.1038/ajg.2010.370  1
2011 Kennedy GT, Coda S, Thompson AJ, Elson DS, Neil MAA, Stamp GW, Thillainayagam A, Viellerobe B, Lacombe F, Dunsby C, French PMW. Fluorescence lifetime imaging endoscopy Progress in Biomedical Optics and Imaging - Proceedings of Spie. 7893. DOI: 10.1117/12.874968  1
2011 Clark PJ, Thompson AJV, Muir AJ. IL28B polymorphisms and treatment of hepatitis C Current Hepatitis Reports. 10: 70-78. DOI: 10.1007/s11901-010-0061-3  1
2010 Urban TJ, Thompson AJ, Bradrick SS, Fellay J, Schuppan D, Cronin KD, Hong L, McKenzie A, Patel K, Shianna KV, McHutchison JG, Goldstein DB, Afdhal N. IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. Hepatology (Baltimore, Md.). 52: 1888-96. PMID 20931559 DOI: 10.1002/Hep.23912  1
2010 Thompson AJ, Clark PJ, McHutchison JG. Hepatitis C virus nonstructural protein 5A inhibitors: novel target-now for new trials and new treatment strategies. Hepatology (Baltimore, Md.). 52: 1162-4. PMID 20812360 DOI: 10.1002/hep.23853  1
2010 Tillmann HL, Thompson AJ, Patel K, Wiese M, Tenckhoff H, Nischalke HD, Lokhnygina Y, Kullig U, Göbel U, Capka E, Wiegand J, Schiefke I, Güthoff W, Grüngreiff K, König I, et al. A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology. 139: 1586-92, 1592.e1. PMID 20637200 DOI: 10.1053/J.Gastro.2010.07.005  1
2010 Rallón NI, Naggie S, Benito JM, Medrano J, Restrepo C, Goldstein D, Shianna KV, Vispo E, Thompson A, McHutchison J, Soriano V. Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients. Aids (London, England). 24: F23-9. PMID 20389235 DOI: 10.1097/Qad.0B013E3283391D6D  1
2010 Thompson AJ, Clark PJ, McHutchison JG. Hepatitis C virus nonstructural protein 5A inhibitors: Novel target - Now for new trials and new treatment strategies Hepatology. 52: 1162-1164. DOI: 10.1002/hep.23853  1
2009 Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, Collins R, Thompson SG, Danesh J. Major lipids, apolipoproteins, and risk of vascular disease. Jama. 302: 1993-2000. PMID 19903920 DOI: 10.1001/Jama.2009.1619  1
2009 Thompson AJ, Colledge D, Rodgers S, Wilson R, Revill P, Desmond P, Mansell A, Visvanathan K, Locarnini S. Stimulation of the interleukin-1 receptor and Toll-like receptor 2 inhibits hepatitis B virus replication in hepatoma cell lines in vitro Antiviral Therapy. 14: 797-808. PMID 19812442 DOI: 10.3851/IMP1294  1
2009 Chang JJ, Sirivichayakul S, Avihingsanon A, Thompson AJ, Revill P, Iser D, Slavin J, Buranapraditkun S, Marks P, Matthews G, Cooper DA, Kent SJ, Cameron PU, Sasadeusz J, Desmond P, et al. Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection. Journal of Virology. 83: 7649-58. PMID 19458009 DOI: 10.1128/JVI.00183-09  1
2009 Etzkorn JM, Davey NG, Thompson AJ, Creba AS, Leblanc CW, Simpson CD, Krogh ET, Gill CG. The Use of MIMS-MS-MS in field locations as an on-line quantitative environmental monitoring technique for trace contaminants in air and water. Journal of Chromatographic Science. 47: 57-66. PMID 19161658 DOI: 10.1093/CHROMSCI/47.1.57  1
2008 Bowden DS, Thompson AJ. New developments in HBV molecular diagnostics and quantitative serology. Hepatology International. 2: 3-11. PMID 19669293 DOI: 10.1007/s12072-008-9051-8  1
2008 Thompson A, Di Angelantonio E, Sarwar N, Erqou S, Saleheen D, Dullaart RP, Keavney B, Ye Z, Danesh J. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. Jama. 299: 2777-88. PMID 18560005 DOI: 10.1001/jama.299.23.2777  1
2007 Chang JJ, Thompson AJV, Visvanathan K, Kent SJ, Cameron PU, Wightman F, Desmond P, Locarnini SA, Lewin SR. The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection Hepatology. 46: 1332-1340. PMID 17924445 DOI: 10.1002/hep.21844  1
2007 Thompson AJ, Locarnini SA. Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunology and Cell Biology. 85: 435-45. PMID 17667934 DOI: 10.1038/sj.icb.7100100  1
2007 Thompson AJ, Ayres A, Yuen L, Bartholomeusz A, Bowden DS, Iser DM, Chen RY, Demediuk B, Shaw G, Bell SJ, Watson KJ, Locarnini SA, Desmond PV. Lamivudine resistance in patients with chronic hepatitis B: role of clinical and virological factors. Journal of Gastroenterology and Hepatology. 22: 1078-85. PMID 17608854 DOI: 10.1111/j.1440-1746.2006.04630.x  1
2007 Visvanathan K, Skinner NA, Thompson AJ, Riordan SM, Sozzi V, Edwards R, Rodgers S, Kurtovic J, Chang J, Lewin S, Desmond P, Locarnini S. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology (Baltimore, Md.). 45: 102-10. PMID 17187404 DOI: 10.1002/hep.21482  1
Show low-probability matches.